JoAnna K Leyenaar1, Tara Lagu2, Meng-Shiou Shieh3, Penelope S Pekow4, Peter K Lindenauer2. 1. Division of Pediatric Hospital Medicine, Department of Pediatrics, Tufts University School of Medicine, Boston, MA. Electronic address: jleyenaar@post.harvard.edu. 2. Center for Quality of Care Research, Baystate Medical Center, Springfield, MA; Division of General Internal Medicine, Baystate Medical Center, Springfield, MA; Department of Medicine, Tufts University School of Medicine, Boston, MA. 3. Center for Quality of Care Research, Baystate Medical Center, Springfield, MA. 4. Center for Quality of Care Research, Baystate Medical Center, Springfield, MA; Department of Public Health, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA.
Abstract
OBJECTIVE: To describe patterns of diagnostic testing and antibiotic management of uncomplicated pneumonia in general community hospitals and children's hospitals within hospitals and to determine the association between diagnostic testing and length of hospital stay. STUDY DESIGN: We conducted a retrospective cohort study of children 1-17 years of age hospitalized with the diagnosis of pneumonia from 2007 to 2010 to hospitals contributing data to Perspective Database Warehouse, assessing patterns of diagnostic testing and antibiotic management. We constructed logistic regression models of log-transformed length of stay (LOS) and grouped treatment models to ascertain whether performance of blood cultures and viral respiratory testing were associated with LOS. RESULTS: A total of 17 299 pneumonia cases occurred at 125 hospitals, with considerable variability in pneumonia management. Only 40 (0.2%) received ampicillin/penicillin G alone or in combination with other antibiotics, and 1318 (7.4%) received macrolide monotherapy as initial antibiotic management. Performance of blood culture and testing for respiratory viruses was associated with a statistically significant longer LOS, but these differences did not persist in grouped treatment models. CONCLUSIONS: We observed greater rates of diagnostic testing in this cohort of structurally diverse hospitals than previously reported at freestanding children's hospitals, with extremely low rates of narrow-spectrum antibiotic use. Tailored antibiotic stewardship initiatives at these hospitals are needed to achieve adherence to national guideline recommendations.
OBJECTIVE: To describe patterns of diagnostic testing and antibiotic management of uncomplicated pneumonia in general community hospitals and children's hospitals within hospitals and to determine the association between diagnostic testing and length of hospital stay. STUDY DESIGN: We conducted a retrospective cohort study of children 1-17 years of age hospitalized with the diagnosis of pneumonia from 2007 to 2010 to hospitals contributing data to Perspective Database Warehouse, assessing patterns of diagnostic testing and antibiotic management. We constructed logistic regression models of log-transformed length of stay (LOS) and grouped treatment models to ascertain whether performance of blood cultures and viral respiratory testing were associated with LOS. RESULTS: A total of 17 299 pneumonia cases occurred at 125 hospitals, with considerable variability in pneumonia management. Only 40 (0.2%) received ampicillin/penicillin G alone or in combination with other antibiotics, and 1318 (7.4%) received macrolide monotherapy as initial antibiotic management. Performance of blood culture and testing for respiratory viruses was associated with a statistically significant longer LOS, but these differences did not persist in grouped treatment models. CONCLUSIONS: We observed greater rates of diagnostic testing in this cohort of structurally diverse hospitals than previously reported at freestanding children's hospitals, with extremely low rates of narrow-spectrum antibiotic use. Tailored antibiotic stewardship initiatives at these hospitals are needed to achieve adherence to national guideline recommendations.
Authors: Tamar Lasky; Frank R Ernst; Jay Greenspan; Shirley Wang; Liliana Gonzalez Journal: Pharmacoepidemiol Drug Saf Date: 2010-11-11 Impact factor: 2.890
Authors: John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson Journal: Clin Infect Dis Date: 2011-08-31 Impact factor: 9.079
Authors: Anna K Weiss; Matthew Hall; Grace E Lee; Matthew P Kronman; Seth Sheffler-Collins; Samir S Shah Journal: Pediatrics Date: 2011-01-10 Impact factor: 7.124
Authors: Thomas V Brogan; Matthew Hall; Derek J Williams; Mark I Neuman; Carlos G Grijalva; Reid W D Farris; Samir S Shah Journal: Pediatr Infect Dis J Date: 2012-10 Impact factor: 2.129
Authors: Ross E Newman; Erin B Hedican; Joshua C Herigon; David D Williams; Arthur R Williams; Jason G Newland Journal: Pediatrics Date: 2012-02-20 Impact factor: 7.124
Authors: Lilliam Ambroggio; Jennifer A Taylor; Loni Philip Tabb; Craig J Newschaffer; Alison A Evans; Samir S Shah Journal: J Pediatr Date: 2012-08-15 Impact factor: 4.406
Authors: Jay G Berry; Matt Hall; David E Hall; Dennis Z Kuo; Eyal Cohen; Rishi Agrawal; Kenneth D Mandl; Holly Clifton; John Neff Journal: JAMA Pediatr Date: 2013-02 Impact factor: 16.193
Authors: Jana C Leary; Kathleen E Walsh; Rebecca A Morin; Elisabeth G Schainker; JoAnna K Leyenaar Journal: J Hosp Med Date: 2019-09-18 Impact factor: 2.960
Authors: Russell J McCulloh; Michael P Koster; Dwight E Yin; Tiffany L Milner; Shawn L Ralston; Vanessa L Hill; Brian K Alverson; Eric A Biondi Journal: PLoS One Date: 2015-02-06 Impact factor: 3.240
Authors: Jessica L Markham; Matt Hall; Jennifer L Goldman; Jessica L Bettenhausen; James C Gay; James Feinstein; Julia Simmons; Stephanie K Doupnik; Jay G Berry Journal: J Hosp Med Date: 2021-03 Impact factor: 2.960